Mirae Asset Global Investments
WX

Mirae Asset Global Investments’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Mirae Asset Global Investments’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-8,462
Closed -$366K – 492
2015
Q3 		$366K Sell
8,462
-39,005
-82% -$1.65M 0.02% 362
2015
Q2 		$2.01M Sell
47,467
-20,582
-30% -$868K 0.06% 211
2015
Q1 		$2.64M Sell
68,049
-171,459
-72% -$6.6M 0.09% 175
2014
Q4 		$8.06M Sell
239,508
-276,715
-54% -$9.77M 0.29% 69
2014
Q3 		$18.1M Sell
516,223
-1,854,183
-78% -$63.6M 0.65% 46
2014
Q2 		$77.9M Buy
2,370,406
+14,028
+0.6% +$480K 1.73% 26
2014
Q1 		$86.9M Buy
2,356,378
+1,225,496
+108% +$45M 2.21% 16
2013
Q4 		$43.4M Buy
1,130,882
+839,846
+289% +$26.5M 1.82% 14
2013
Q3 		$7.97M Buy
+291,036
New +$6.9M 0.36% 49

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Mirae Asset Global Investments's WX Position: Q4 2015 in Review

Mirae Asset Global Investments sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 8,462 shares — an estimated $366K sold.

Mirae Asset Global Investments first reported a position in WX in Q3 2013 and held it in 9 quarters. The position peaked at $86.9M in Q1 2014. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Mirae Asset Global Investments reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Mirae Asset Global Investments sold 8,462 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $366K.
  • Mirae Asset Global Investments first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 9 quarters.
  • Mirae Asset Global Investments's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $86.9M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Mirae Asset Global Investments's 13F filing for Q4 2015, filed 12 Feb 2016.